M. Nicola

发表

roved Clinical Outcome in Indolent B-Cell Lymphoma ients Vaccinated with Autologous Tumor Cells

M. Colombo, C. Carlo-Stella, I. Bongarzone, 2010 .

Successful in vivo purging of CD34-containing peripheral blood harvests in mantle cell and indolent lymphoma: evidence for a role of both chemotherapy and rituximab infusion

A. Pileri, G. Bonadonna, M. Di Nicola, 2000 .

Improved clinical outcome in indolent B-cell lymphoma patients vaccinated with autologous tumor cells experiencing immunogenic death.

M. Colombo, C. Carlo-Stella, M. Di Nicola, 2010, Cancer research.

Non-Hodgkin’s Lymphomas

R. Zappasodi, M. Nicola, 1993 .

Adenovirus vectors for gene transduction into mobilized blood CD34+ cells

S. Shammah, S. Siena, F. Ravagnani, 1998, Gene Therapy.

Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGF- β and PD-L1, in Second-Line Treatment of Patients With NSCLC: Results From an Expansion Cohort of a Phase 1 Trial

Christoph, E. Felip, L. Paz-Ares, 2021 .

targets of retroviral-mediated gene transfer Human peripheral blood hematopoietic progenitors are optimal

G. Bonadonna, S. Siena, A. Gianni, 2011 .

Practical aspects of flow cytometry to guide large-scale collection of circulating hematopoietic progenitors for autologous transplantation in cancer patients

G. Bonadonna, S. Siena, F. Ravagnani, 1992 .

Clinical implications of the heterogeneity of hematopoietic progenitors elicited in peripheral blood by anticancer therapy with cyclophosphamide and cytokine(s)

P. Strippoli, L. Bonsi, S. Siena, 1993, Stem cells.

High-dose ara-C with autologous peripheral blood progenitor cell support induces a marked progenitor cell mobilization: an indication for patients at risk for low mobilization

A. Pileri, A. Gallamini, D. Caracciolo, 2002, Bone Marrow Transplantation.

HSPH1 Inhibition Down-regulates Bcl-6 and c-Myc and Hampers the Growth of Human Aggressive B-cell Non-Hodgkin Lymphoma

C. Tripodo, F. Braud, R. Zappasodi, 2015 .

HSPH 1 inhibition downregulates Bcl-6 and c-Myc and hampers the growth of human aggressive B-cell non-Hodgkin lymphoma

C. Tripodo, N. Zaffaroni, F. Braud, 2015 .

TARC before ASCT Is Highly Predictive of Outcome in Patients with Relapsed or Refractory (R/R) Classical Hodgkin Lymphoma (cHL) after First-Line Therapy

P. Corradini, A. Guidetti, L. Farina, 2016 .

High-dose sequential chemotherapy and in vivo rituximab-purged stem cell autografting in mantle cell lymphoma: a 10-year update of the R-HDS regimen

T. Barbui, C. Carlo-Stella, M. Martelli, 2009, Bone Marrow Transplantation.

Successful second autologous engraftment after long duration storage of hematopoietic stem cells

F. Ravagnani, V. Montefusco, M. Milanesi, 2013, Bone Marrow Transplantation.

Results from a second-line (2L) NSCLC cohort treated with M7824 (MSB0011359C), a bifunctional fusion protein targeting TGF-β and PD-L1.

E. Felip, L. Paz-Ares, B. Cho, 2018 .

High response rate and manageable toxicity with an intensive, short‐term chemotherapy programme for Burkitt's lymphoma in adults

C. Carlo-Stella, M. Massimino, A. Guidetti, 2004, British journal of haematology.

Early Hematopoietic Zinc Finger protein ( EHZF ) , the human homologue to mouse

A. Hata, S. Venuta, M. Moore, 2003 .

Cancer vaccines and active immunotherapy

R. Zappasodi, L. Rivoltini, P. Filipazzi, 2013 .

Safety, Tolerability and Activity of Ofatumumab, Bendamustine and Dexamethasone Combination As First-Line Treatment of Mantle-Cell Lymphoma in the Elderly: A Multicenter Study

C. Carlo-Stella, V. Rizzoli, A. Gallamini, 2011 .

Prolonged survival in poor-risk diffuse large B-cell lymphoma following front-line treatment with rituximab-supplemented, early-intensified chemotherapy with multiple autologous hematopoietic stem cell support: a multicenter study by GITIL (Gruppo Italiano Terapie Innovative nei Linfomi)

M. Boccadoro, M. Ladetto, A. Gallamini, 2007, Leukemia.

Artificial Antigen Presenting Cells With Preclustered anti-CD28/-CD3/-LFA-1 Monoclonal Antibodies Are Highly Effective To Induce The Ex-Vivo Expansion Of Functional Human Antitumor T Cells.

S. Albani, A. Anichini, C. Carlo-Stella, 2007 .

Efficacy and safety of high-dose chemotherapy with in vivo purged auto-SCT in relapsed follicular lymphoma: long-term follow-up

C. Carlo-Stella, A. Guidetti, M. Magni, 2010, Bone Marrow Transplantation.

Cancer esearch oenvironment and Immunology or-Reactive CD 8 + Early Effector T Cells Identified at R or Site in Primary and Metastatic Melanoma

A. Anichini, F. Ravagnani, A. Molla, 2010 .

Benefits of blood cell transplant cryopreservation with oxypolygelatine (Gelifundol) plasma substitute

S. Siena, F. Ravagnani, M. Milanesi, 1997, Bone Marrow Transplantation.

Rituximab-Supplemented High-Dose Sequential (HDS) Chemotherapy with Autograft Is Highly Effective in High-Risk (aaIPI 2–3) Diffuse Large B-Cell Lymphoma: Results of a Prospective Multicenter Study on 91 Consecutive Patients Treated at Diagnosis

M. Boccadoro, M. Ladetto, A. Gallamini, 2004 .

High dose hydroxyurea in collection of Philadelphia chromosome-negative stem cells in chronic myeloid leukaemia.

J. Hardingham, B. Kuss, M. Nicola, 1993, Leukemia & lymphoma.

In Vitro and In Vivo Anti-Lymphoma Activity of the Anti-HLA-DR Monoclonal Antibody 1D09C3.

C. Carlo-Stella, F. Formelli, M. Milanesi, 2004 .

Chemoimmunotherapy with R-CHOP or High Dose Sequential Therapy with Autologous Stem Cell Transplantation (R-HDS) for High Risk Diffuse Large B-Cell Lymphomas Patients: Results of the Randomized R-HDS0305 Trial by Gruppo Italiano Terapie Innovative Nei Linfomi (GITIL)

T. Barbui, A. Rossi, G. Pizzolo, 2012 .

7100 High-dose sequential chemotherapy versus conventional-dose chemotherapy as first-line treatment for advanced poor prognosis germ-cell tumors: a multicenter Phase III Italian trial

C. Carlo-Stella, A. Necchi, N. Nicolai, 2009 .

Massive ex vivo generation of functional dendritic cells from mobilized CD34+ blood progenitors for anticancer therapy.

A. Anichini, M. Di Nicola, G. Parmiani, 1995, Experimental hematology.

Safety and activity of a new intensive short‐term chemoimmunotherapy in HIV‐positive patients with Burkitt lymphoma

U. Tirelli, A. Ferreri, G. Rossi, 2012, British journal of haematology.

Human peripheral blood hematopoietic progenitors are optimal targets of retroviral-mediated gene transfer.

G. Bonadonna, M. Di Nicola, S. Siena, 1992, Blood.

Quantization of CD34+ Peripheral Blood Hematopoietic Progenitors for Autografting in Cancer Patients

G. Bonadonna, M. Di Nicola, S. Siena, 1993, The International journal of artificial organs.

Recombinant human interleukin-3 and recombinant human granulocyte-macrophage colony-stimulating factor administered in vivo after high-dose cyclophosphamide cancer chemotherapy: effect on hematopoiesis and microenvironment in human bone marrow.

G. Cattoretti, M. Di Nicola, S. Siena, 1992, Blood.

Phase II Trial of Combination of the Histone Deacetylase Inhibitor ITF2357 and Meclorethamine Demonstrates Clinical Activity and Safety in Heavily Pretreated Patients with Relapsed/Refractory Hodgkin Lymphoma (HL)

C. Carlo-Stella, P. Valagussa, P. Corradini, 2008 .

Autologous dendritic cells derived from CD34+ progenitors and from monocytes are not functionally equivalent antigen-presenting cells in the induction of melan-A/Mart-1(27-35)-specific CTLs from peripheral blood lymphocytes of melanoma patients with low frequency of CTL precursors.

A. Anichini, M. Di Nicola, G. Parmiani, 1997, Cancer research.

Abstract CT022: CheckMate 848: A randomized, open-label, phase 2 study of nivolumab in combination with ipilimumab or nivolumab monotherapy in patients with advanced or metastatic solid tumors of high tumor mutational burden

P. Ascierto, M. Burotto, T. Ciuleanu, 2022, Cancer Research.

Quilty Effect Has the Features of Lymphoid Neogenesis and Shares CXCL13–CXCR5 Pathway With Recurrent Acute Cardiac Rejections

M. Di Nicola, E. Ballone, S. Contento, 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Efficacy, toxicity, and applicability of high-dose sequential chemotherapy as adjuvant treatment in operable breast cancer with 10 or more involved axillary nodes: five-year results.

A. Luini, G. Bonadonna, M. Greco, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Granulocyte-macrophage colony-stimulating factor or granulocyte colony-stimulating factor infusion makes high-dose etoposide a safe outpatient regimen that is effective in lymphoma and myeloma patients.

A. Pileri, G. Bonadonna, M. Di Nicola, 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Bond, H.M. et al. Early hematopoietic zinc finger protein (EHZF), the human homolog to mouse Evi3, is highly expressed in primitive human hematopoietic cells. Blood 103, 2062-2070

A. Hata, S. Venuta, G. Morrone, 2004 .

High-dose sequential chemo-radiotherapy with peripheral blood progenitor cell support for relapsed or refractory Hodgkin's disease--a 6-year update.

G. Bonadonna, P. Valagussa, M. Di Nicola, 1993, Annals of oncology : official journal of the European Society for Medical Oncology.

Successful in vivo purging of CD34-containing peripheral blood harvests in mantle cell and indolent lymphoma: evidence for a role of both chemotherapy and rituximab infusion.

A. Pileri, G. Bonadonna, M. Di Nicola, 2000, Blood.

High-Dose Myeloablative Zevalin Radioimmunotherapy with Tandem Stem-Cell Autografting Has Promising Activity, Minimal Toxicity and Full Feasibility in an Outpatient Setting.

C. Carlo-Stella, P. Valagussa, E. Seregni, 2006 .

Clinical Activity and Safety of the Combined Therapy with the AKT Inhibitor Perifosine and the Multikinase Inhibitor Sorafenib In Heavily Pretreated Patients with Relapsed/Refractory Lymphomas: Preliminary Results of a Phase II Trial

C. Carlo-Stella, P. Corradini, A. Guidetti, 2010 .

Cancer esearch oenvironment and Immunology or-Reactive CD 8 + Early Effector T Cells Identified at R or Site in Primary and Metastatic Melanoma

A. Anichini, F. Ravagnani, A. Molla, 2010 .